MY159491A - Disubstituted phthalazine hedgehog pathway antagonists - Google Patents
Disubstituted phthalazine hedgehog pathway antagonistsInfo
- Publication number
- MY159491A MY159491A MYPI2010005097A MYPI2010005097A MY159491A MY 159491 A MY159491 A MY 159491A MY PI2010005097 A MYPI2010005097 A MY PI2010005097A MY PI2010005097 A MYPI2010005097 A MY PI2010005097A MY 159491 A MY159491 A MY 159491A
- Authority
- MY
- Malaysia
- Prior art keywords
- hedgehog pathway
- pathway antagonists
- disubstituted phthalazine
- phthalazine hedgehog
- disubstituted
- Prior art date
Links
- 239000005557 antagonist Substances 0.000 title abstract 2
- 230000037361 pathway Effects 0.000 title abstract 2
- 241000289669 Erinaceus europaeus Species 0.000 title 1
- LFSXCDWNBUNEEM-UHFFFAOYSA-N phthalazine Chemical class C1=NN=CC2=CC=CC=C21 LFSXCDWNBUNEEM-UHFFFAOYSA-N 0.000 title 1
- -1 1,4-DISUBSTITUTED PHTHALAZINE Chemical class 0.000 abstract 1
- 241000027355 Ferocactus setispinus Species 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US4872908P | 2008-04-29 | 2008-04-29 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MY159491A true MY159491A (en) | 2017-01-13 |
Family
ID=40846962
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MYPI2010005097A MY159491A (en) | 2008-04-29 | 2009-04-01 | Disubstituted phthalazine hedgehog pathway antagonists |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US7981892B2 (OSRAM) |
| EP (1) | EP2294061A2 (OSRAM) |
| JP (1) | JP5442717B2 (OSRAM) |
| KR (1) | KR101260116B1 (OSRAM) |
| CN (1) | CN102066353B (OSRAM) |
| AU (1) | AU2009241561B2 (OSRAM) |
| BR (1) | BRPI0911618A2 (OSRAM) |
| CA (1) | CA2723042A1 (OSRAM) |
| CO (1) | CO6300945A2 (OSRAM) |
| CR (1) | CR11741A (OSRAM) |
| DO (1) | DOP2010000302A (OSRAM) |
| EA (1) | EA201071248A1 (OSRAM) |
| EC (1) | ECSP10010577A (OSRAM) |
| HN (1) | HN2010002157A (OSRAM) |
| IL (1) | IL208211A0 (OSRAM) |
| MA (1) | MA32349B1 (OSRAM) |
| MX (1) | MX2010011948A (OSRAM) |
| MY (1) | MY159491A (OSRAM) |
| NZ (1) | NZ588001A (OSRAM) |
| UA (1) | UA102250C2 (OSRAM) |
| WO (1) | WO2009134574A2 (OSRAM) |
| ZA (1) | ZA201006695B (OSRAM) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EA201071248A1 (ru) | 2008-04-29 | 2011-06-30 | Эли Лилли Энд Компани | Дизамещенные фталазиновые антагонисты пути hedgehog |
| HRP20130527T1 (en) * | 2008-11-03 | 2013-07-31 | Eli Lilly And Company | Disubstituted phthalazine hedgehog pathway antagonists |
| CA2743483C (en) | 2008-11-17 | 2014-03-11 | Eli Lilly And Company | Tetrasubstituted pyridazine hedgehog pathway antagonists |
| CA2743264C (en) | 2008-11-17 | 2014-02-18 | Julia Marie Clay | Tetrasubstituted pyridazines hedgehog pathway antagonists |
| AR077014A1 (es) * | 2009-06-19 | 2011-07-27 | Lilly Co Eli | Compuesto derivado de ftalazina 1,4-disustituida, composicion farmaceutica que lo comprende y uso para preparar un medicamento util para el tratamiento de cancer |
| PH12012500911A1 (en) * | 2009-11-18 | 2012-11-26 | Novartis Ag | Methods and compositions for treating solid tumors and other malignancies |
| CN102702108A (zh) * | 2012-06-27 | 2012-10-03 | 上海大学 | 1,2-二氢酞嗪类化合物及其合成方法 |
| WO2014043608A2 (en) * | 2012-09-17 | 2014-03-20 | Duke University | Smoothened modulators and methods of use thereof |
| CN102863393A (zh) * | 2012-09-26 | 2013-01-09 | 上海大学 | 1,2-二氢酞嗪类化合物及其合成方法 |
| GB201309508D0 (en) | 2013-05-28 | 2013-07-10 | Redx Pharma Ltd | Compounds |
| GB2528298A (en) * | 2014-07-16 | 2016-01-20 | Redx Pharma Plc | Compounds |
| CN105985321B (zh) * | 2015-02-11 | 2018-10-26 | 复旦大学 | 吡唑酞嗪化合物及其制备方法和用途 |
| CN105985320B (zh) * | 2015-02-11 | 2018-10-26 | 复旦大学 | 苄基酞嗪化合物及其制备方法和用途 |
| CN105985319B (zh) * | 2015-02-11 | 2019-02-26 | 复旦大学 | 芳基酞嗪化合物及其制备方法和用途 |
| CN107163028B (zh) * | 2017-05-24 | 2019-07-12 | 东南大学 | 一种苯甲酰胺类Hedgehog抑制剂及其制备方法和应用 |
| JP2023546536A (ja) | 2020-10-13 | 2023-11-02 | エンデバー バイオメディシンズ， インコーポレイテッド | 線維症を処置する方法 |
| US20240124451A1 (en) * | 2022-09-23 | 2024-04-18 | Merck Sharp & Dohme Llc | Phthalazine derivatives useful as inhibitors of nod-like receptor protein 3 |
| WO2025188802A1 (en) | 2024-03-05 | 2025-09-12 | Endeavor Biomedicines, Inc. | Methods of improving lung function |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1293565A (en) * | 1969-05-03 | 1972-10-18 | Aspro Nicholas Ltd | Aminophthalazines and pharmaceutical compositions thereof |
| JP4169368B2 (ja) | 1996-01-15 | 2008-10-22 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | 脈管形成阻害性ピリダジンアミン |
| US6432970B2 (en) * | 1998-04-09 | 2002-08-13 | Johns Hopkins University School Of Medicine | Inhibitors of hedgehog signaling pathways, compositions and uses related thereto |
| EP1067939B1 (en) | 1998-04-09 | 2015-09-16 | The Johns Hopkins University | Use of steroidal alkaloid derivatives as inhibitors of hedgehog protein signaling pathways |
| DE60016402T2 (de) | 1999-06-08 | 2005-10-27 | Lorantis Ltd. | Therapeutische verwendung eines inhibitors des hedgehog signalübertragungsweges |
| EP1496905B1 (en) | 2002-04-22 | 2008-08-13 | Johns Hopkins University School of Medicine | Modulators of hedgehog signaling pathways, compositions and uses related thereto |
| AU2003265853A1 (en) | 2002-08-29 | 2004-03-19 | Curis, Inc. | Hedgehog antagonists, methods and uses related thereto |
| US8067608B2 (en) | 2003-09-29 | 2011-11-29 | The Johns Hopkins University | Hedgehog pathway antagonists |
| WO2005080378A1 (ja) | 2004-02-24 | 2005-09-01 | Mitsubishi Pharma Corporation | 縮合ピリダジン誘導体 |
| CN1984904A (zh) | 2004-05-08 | 2007-06-20 | 神经能质公司 | 3－芳基－5,6－二取代哒嗪 |
| EP1789390B1 (en) | 2004-09-02 | 2011-11-09 | Genentech, Inc. | Pyridyl inhibitors of hedgehog signalling |
| EP1900731A1 (de) | 2006-09-07 | 2008-03-19 | Bayer Schering Pharma Aktiengesellschaft | N-(1-Phthalazin-1-yl-piperidin-4-yl)-amide als EP2-Rezeptor Modulatoren |
| AU2008225766B2 (en) * | 2007-03-15 | 2012-06-07 | Novartis Ag | Organic compounds and their uses |
| AU2008269128B2 (en) * | 2007-06-25 | 2012-08-02 | Amgen Inc. | Phthalazine compounds, compositions and methods of use |
| AU2008300019A1 (en) | 2007-09-07 | 2009-03-19 | Amgen Inc. | Annelated pyridazines for the treatment of tumors driven by inappropriate hedgehog signalling |
| EA201071248A1 (ru) | 2008-04-29 | 2011-06-30 | Эли Лилли Энд Компани | Дизамещенные фталазиновые антагонисты пути hedgehog |
| US20100041663A1 (en) | 2008-07-18 | 2010-02-18 | Novartis Ag | Organic Compounds as Smo Inhibitors |
| HRP20130527T1 (en) | 2008-11-03 | 2013-07-31 | Eli Lilly And Company | Disubstituted phthalazine hedgehog pathway antagonists |
| CA2743264C (en) | 2008-11-17 | 2014-02-18 | Julia Marie Clay | Tetrasubstituted pyridazines hedgehog pathway antagonists |
| CA2743483C (en) | 2008-11-17 | 2014-03-11 | Eli Lilly And Company | Tetrasubstituted pyridazine hedgehog pathway antagonists |
| AR077014A1 (es) * | 2009-06-19 | 2011-07-27 | Lilly Co Eli | Compuesto derivado de ftalazina 1,4-disustituida, composicion farmaceutica que lo comprende y uso para preparar un medicamento util para el tratamiento de cancer |
-
2009
- 2009-04-01 EA EA201071248A patent/EA201071248A1/ru unknown
- 2009-04-01 EP EP09739376A patent/EP2294061A2/en not_active Withdrawn
- 2009-04-01 CA CA2723042A patent/CA2723042A1/en not_active Abandoned
- 2009-04-01 CN CN2009801152085A patent/CN102066353B/zh not_active Expired - Fee Related
- 2009-04-01 US US12/935,655 patent/US7981892B2/en not_active Expired - Fee Related
- 2009-04-01 UA UAA201012722A patent/UA102250C2/ru unknown
- 2009-04-01 MY MYPI2010005097A patent/MY159491A/en unknown
- 2009-04-01 JP JP2011507512A patent/JP5442717B2/ja not_active Expired - Fee Related
- 2009-04-01 MX MX2010011948A patent/MX2010011948A/es active IP Right Grant
- 2009-04-01 KR KR1020107024209A patent/KR101260116B1/ko not_active Expired - Fee Related
- 2009-04-01 NZ NZ588001A patent/NZ588001A/en not_active IP Right Cessation
- 2009-04-01 BR BRPI0911618A patent/BRPI0911618A2/pt not_active IP Right Cessation
- 2009-04-01 AU AU2009241561A patent/AU2009241561B2/en not_active Ceased
- 2009-04-01 WO PCT/US2009/039065 patent/WO2009134574A2/en not_active Ceased
-
2010
- 2010-09-16 IL IL208211A patent/IL208211A0/en unknown
- 2010-09-17 ZA ZA2010/06695A patent/ZA201006695B/en unknown
- 2010-10-11 DO DO2010000302A patent/DOP2010000302A/es unknown
- 2010-10-15 CR CR11741A patent/CR11741A/es unknown
- 2010-10-21 HN HN2010002157A patent/HN2010002157A/es unknown
- 2010-10-25 MA MA33284A patent/MA32349B1/fr unknown
- 2010-10-27 EC EC2010010577A patent/ECSP10010577A/es unknown
- 2010-11-11 CO CO10141824A patent/CO6300945A2/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| JP5442717B2 (ja) | 2014-03-12 |
| CR11741A (es) | 2011-01-05 |
| KR101260116B1 (ko) | 2013-05-02 |
| MA32349B1 (fr) | 2011-06-01 |
| HN2010002157A (es) | 2014-09-08 |
| US7981892B2 (en) | 2011-07-19 |
| ECSP10010577A (es) | 2010-11-30 |
| AU2009241561B2 (en) | 2013-05-16 |
| ZA201006695B (en) | 2012-09-26 |
| DOP2010000302A (es) | 2010-11-15 |
| CN102066353B (zh) | 2013-12-11 |
| EA201071248A1 (ru) | 2011-06-30 |
| CO6300945A2 (es) | 2011-07-21 |
| CN102066353A (zh) | 2011-05-18 |
| UA102250C2 (ru) | 2013-06-25 |
| EP2294061A2 (en) | 2011-03-16 |
| US20110046143A1 (en) | 2011-02-24 |
| IL208211A0 (en) | 2010-12-30 |
| AU2009241561A1 (en) | 2009-11-05 |
| KR20100126580A (ko) | 2010-12-01 |
| NZ588001A (en) | 2012-06-29 |
| WO2009134574A3 (en) | 2014-09-04 |
| JP2011527666A (ja) | 2011-11-04 |
| CA2723042A1 (en) | 2009-11-05 |
| MX2010011948A (es) | 2010-12-14 |
| WO2009134574A2 (en) | 2009-11-05 |
| BRPI0911618A2 (pt) | 2019-09-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JO2931B1 (en) | Double-substituted phthalazin compounds as antagonists of the cell-specific factor pathway | |
| MY159491A (en) | Disubstituted phthalazine hedgehog pathway antagonists | |
| TN2011000166A1 (en) | Disubstituted phthalazine hedgehog pathway antagonists | |
| EA201171367A1 (ru) | Винилиндазолильные соединения | |
| MX2009012625A (es) | Metodos para el tratamiento, diagnostico y deteccion de trastornos asociados con el fgf21. | |
| MX2009008347A (es) | Oxabicicloheptanos y oxabicicloheptenos, su preparacion y uso. | |
| MX2009008222A (es) | Antagonistas de activina-actriia y usos para tratar o prevenir cancer de mama. | |
| JO2788B1 (en) | Amido phenoxyendazole compounds beneficial as C-MET inhibitors | |
| MY153915A (en) | Organic compounds | |
| TW201713640A (en) | Bruton's tyrosine kinase inhibitors | |
| MX2009008430A (es) | Anticuerpos anti-robo4 y sus usos. | |
| MX2010003117A (es) | Compuestos y composiciones como moduladores de la actividad de gpr119. | |
| MX2009009491A (es) | Compuestos y composiciones como moduladores de la actividad del gpr119. | |
| MY186456A (en) | Quinazoline carboxamide azetidines | |
| IN2012DN02471A (OSRAM) | ||
| EA200971068A1 (ru) | Триазолиламинопиримидиновые соединения | |
| MX2009011346A (es) | Tapentadol para tratamiento de dolor con artritis. | |
| EA201170700A1 (ru) | Тетразамещенные пиридазины в качестве антагонистов пути hedgehog | |
| MX2009009693A (es) | Metodos para activar irs-1 y akt. | |
| EA200971067A1 (ru) | Триазолиламинопиримидиновые соединения | |
| NZ593169A (en) | Anticancer compounds | |
| TN2010000489A1 (en) | Disubstituted phthalazine hedgehog pathway antagonists | |
| CY1114078T1 (el) | Ανταγωνιστες διυποκατεστημενης φθαλαζινης του μονοπατιου hedgehog | |
| TN2012000552A1 (en) | An antitumoral combination comprising ombrabulin, a taxane derivative and a platinum derivative | |
| UA101379C2 (en) | Amidophenoxyindazoles useful in the treatment of cancer |